BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30105762)

  • 1. Epithelial-to-mesenchymal transition signature assessment in colorectal cancer quantifies tumour stromal content rather than true transition.
    McCorry AM; Loughrey MB; Longley DB; Lawler M; Dunne PD
    J Pathol; 2018 Dec; 246(4):422-426. PubMed ID: 30105762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal contribution to the colorectal cancer transcriptome.
    Isella C; Terrasi A; Bellomo SE; Petti C; Galatola G; Muratore A; Mellano A; Senetta R; Cassenti A; Sonetto C; Inghirami G; Trusolino L; Fekete Z; De Ridder M; Cassoni P; Storme G; Bertotti A; Medico E
    Nat Genet; 2015 Apr; 47(4):312-9. PubMed ID: 25706627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A partial epithelial-mesenchymal transition signature for highly aggressive colorectal cancer cells that survive under nutrient restriction.
    Pastorino GA; Sheraj I; Huebner K; Ferrero G; Kunze P; Hartmann A; Hampel C; Husnugil HH; Maiuthed A; Gebhart F; Schlattmann F; Gulec Taskiran AE; Oral G; Palmisano R; Pardini B; Naccarati A; Erlenbach-Wuensch K; Banerjee S; Schneider-Stock R
    J Pathol; 2024 Mar; 262(3):347-361. PubMed ID: 38235615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a predictive model for stromal content in prostate cancer samples to improve signature performance.
    Boufaied N; Takhar M; Nash C; Erho N; Bismar TA; Davicioni E; Thomson AA
    J Pathol; 2019 Dec; 249(4):411-424. PubMed ID: 31206668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive profiling of novel epithelial-mesenchymal transition mediators and their clinical significance in colorectal cancer.
    Ishikawa S; Nishida N; Fujino S; Ogino T; Takahashi H; Miyoshi N; Uemura M; Satoh T; Yamamoto H; Mizushima T; Doki Y; Eguchi H
    Sci Rep; 2021 Jun; 11(1):11759. PubMed ID: 34083586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic protein and Notch signalling crosstalk in poor-prognosis, mesenchymal-subtype colorectal cancer.
    Irshad S; Bansal M; Guarnieri P; Davis H; Al Haj Zen A; Baran B; Pinna CMA; Rahman H; Biswas S; Bardella C; Jeffery R; Wang LM; East JE; Tomlinson I; Lewis A; Leedham SJ
    J Pathol; 2017 Jun; 242(2):178-192. PubMed ID: 28299802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional mimicry by tumor-associated stroma.
    Kim H; Verhaak RG
    Nat Genet; 2015 Apr; 47(4):307-9. PubMed ID: 25814306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional molecules in mesothelial-to-mesenchymal transition revealed by transcriptome analyses.
    Namvar S; Woolf AS; Zeef LA; Wilm T; Wilm B; Herrick SE
    J Pathol; 2018 Aug; 245(4):491-501. PubMed ID: 29774544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas.
    McCart Reed AE; Kutasovic JR; Vargas AC; Jayanthan J; Al-Murrani A; Reid LE; Chambers R; Da Silva L; Melville L; Evans E; Porter A; Papadimos D; Thompson EW; Lakhani SR; Simpson PT
    J Pathol; 2016 Mar; 238(4):489-94. PubMed ID: 26510554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buds, clusters, and transitions in 21st century colorectal carcinoma: revolution or reinvention?
    Feakins RM; Loughrey MB; Silver A
    J Pathol; 2023 Oct; 261(2):121-124. PubMed ID: 37565277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching.
    De Smedt L; Palmans S; Andel D; Govaere O; Boeckx B; Smeets D; Galle E; Wouters J; Barras D; Suffiotti M; Dekervel J; Tousseyn T; De Hertogh G; Prenen H; Tejpar S; Lambrechts D; Sagaert X
    Br J Cancer; 2017 Jan; 116(1):58-65. PubMed ID: 27884016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
    Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
    Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour budding and poorly differentiated clusters in colon cancer - different manifestations of partial epithelial-mesenchymal transition.
    Pavlič A; Boštjančič E; Kavalar R; Ilijevec B; Bonin S; Zanconati F; Zidar N
    J Pathol; 2022 Nov; 258(3):278-288. PubMed ID: 36062412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus molecular subtype classification of colorectal adenomas.
    Komor MA; Bosch LJ; Bounova G; Bolijn AS; Delis-van Diemen PM; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; van Grieken NC; Carvalho B; Wessels LF; Jimenez CR; Fijneman RJ; Meijer GA;
    J Pathol; 2018 Nov; 246(3):266-276. PubMed ID: 29968252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal Signals Dominate Gene Expression Signature Scores That Aim to Describe Cancer Cell-intrinsic Stemness or Mesenchymality Characteristics.
    Kreis J; Aybey B; Geist F; Brors B; Staub E
    Cancer Res Commun; 2024 Feb; 4(2):516-529. PubMed ID: 38349551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidylate synthase is functionally associated with ZEB1 and contributes to the epithelial-to-mesenchymal transition of cancer cells.
    Siddiqui A; Vazakidou ME; Schwab A; Napoli F; Fernandez-Molina C; Rapa I; Stemmler MP; Volante M; Brabletz T; Ceppi P
    J Pathol; 2017 Jun; 242(2):221-233. PubMed ID: 28337746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGFR4 promotes stroma-induced epithelial-to-mesenchymal transition in colorectal cancer.
    Liu R; Li J; Xie K; Zhang T; Lei Y; Chen Y; Zhang L; Huang K; Wang K; Wu H; Wu M; Nice EC; Huang C; Wei Y
    Cancer Res; 2013 Oct; 73(19):5926-35. PubMed ID: 23943801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients.
    Tan TZ; Miow QH; Miki Y; Noda T; Mori S; Huang RY; Thiery JP
    EMBO Mol Med; 2014 Oct; 6(10):1279-93. PubMed ID: 25214461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of EMT-Related Genes in Hybrid E/M Colorectal Cancer Cells Determines Fibroblast Activation and Collagen Remodeling.
    Druzhkova I; Shirmanova M; Ignatova N; Dudenkova V; Lukina M; Zagaynova E; Safina D; Kostrov S; Didych D; Kuzmich A; Sharonov G; Rakitina O; Alekseenko I; Sverdlov E
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.